Literature DB >> 19643181

The physiological and pathophysiological role of PRMT1-mediated protein arginine methylation.

Thomas B Nicholson1, Taiping Chen, Stéphane Richard.   

Abstract

Post-translational modifications are well-known effectors in DNA damage signaling and epigenetic gene expression. Protein arginine methylation is a covalent modification that results in the addition of methyl groups to the nitrogen atoms of the arginine side chains and is catalyzed by a family of protein arginine methyltransferases (PRMTs). In the past, arginine methylation was mainly observed on abundant proteins such as RNA-binding proteins and histones, but recent advances have revealed a plethora of arginine-methylated proteins implicated in a variety of cellular processes including signal transduction, epigenetic regulation and DNA repair pathways. Herein, we discuss these recent advances, focusing on the role of PRMT1, the major asymmetric arginine methyltransferase, in cellular processes and its link to human diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19643181     DOI: 10.1016/j.phrs.2009.07.006

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  56 in total

Review 1.  Small Molecule Inhibitors of Protein Arginine Methyltransferases.

Authors:  Hao Hu; Kun Qian; Meng-Chiao Ho; Y George Zheng
Journal:  Expert Opin Investig Drugs       Date:  2016-02-16       Impact factor: 6.206

2.  Protein arginine methyltransferase biology in humans during acute and chronic skeletal muscle plasticity.

Authors:  Tiffany L vanLieshout; Jacob T Bonafiglia; Brendon J Gurd; Vladimir Ljubicic
Journal:  J Appl Physiol (1985)       Date:  2019-08-01

3.  Clinical evaluation of PRMT1 gene expression in breast cancer.

Authors:  Konstantina Mathioudaki; Andreas Scorilas; Alexandros Ardavanis; Peggy Lymberi; Evangelos Tsiambas; Marina Devetzi; Aikaterini Apostolaki; Maroulio Talieri
Journal:  Tumour Biol       Date:  2011-01-13

Review 4.  Kinase consensus sequences: a breeding ground for crosstalk.

Authors:  Heather L Rust; Paul R Thompson
Journal:  ACS Chem Biol       Date:  2011-07-15       Impact factor: 5.100

5.  Integrative analysis reveals an outcome-associated and targetable pattern of p53 and cell cycle deregulation in diffuse large B cell lymphoma.

Authors:  Stefano Monti; Bjoern Chapuy; Kunihiko Takeyama; Scott J Rodig; Yansheng Hao; Kelly T Yeda; Haig Inguilizian; Craig Mermel; Treeve Currie; Ahmet Dogan; Jeffery L Kutok; Rameen Beroukhim; Donna Neuberg; Thomas M Habermann; Gad Getz; Andrew L Kung; Todd R Golub; Margaret A Shipp
Journal:  Cancer Cell       Date:  2012-09-11       Impact factor: 31.743

Review 6.  The role of asymmetric and symmetric dimethylarginines in renal disease.

Authors:  Edzard Schwedhelm; Rainer H Böger
Journal:  Nat Rev Nephrol       Date:  2011-03-29       Impact factor: 28.314

7.  Arginine methylation of BCL-2 antagonist of cell death (BAD) counteracts its phosphorylation and inactivation by Akt.

Authors:  Jun-ichi Sakamaki; Hiroaki Daitoku; Katsuya Ueno; Ayano Hagiwara; Kazuyuki Yamagata; Akiyoshi Fukamizu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-28       Impact factor: 11.205

8.  Protein arginine methyltransferase 1 promoted the growth and migration of cancer cells in esophageal squamous cell carcinoma.

Authors:  Weizheng Zhou; Hui Yue; Chunguang Li; Hezhong Chen; Yang Yuan
Journal:  Tumour Biol       Date:  2015-09-22

9.  Methyltransferase PRMT1 is a binding partner of HBx and a negative regulator of hepatitis B virus transcription.

Authors:  Shirine Benhenda; Aurélie Ducroux; Lise Rivière; Bijan Sobhian; Michael D Ward; Sarah Dion; Olivier Hantz; Ulrike Protzer; Marie-Louise Michel; Monsef Benkirane; Oliver J Semmes; Marie-Annick Buendia; Christine Neuveut
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

10.  Oncogenic Functions of Gli1 in Pancreatic Adenocarcinoma Are Supported by Its PRMT1-Mediated Methylation.

Authors:  Yan Wang; Jung-Mao Hsu; Ya'an Kang; Yongkun Wei; Pei-Chih Lee; Shing-Jyh Chang; Yi-Hsin Hsu; Jennifer L Hsu; Hung-Ling Wang; Wei-Chao Chang; Chia-Wei Li; Hsin-Wei Liao; Shih-Shin Chang; Weiya Xia; How-Wen Ko; Chao-Kai Chou; Jason B Fleming; Huamin Wang; Rosa F Hwang; Yue Chen; Jun Qin; Mien-Chie Hung
Journal:  Cancer Res       Date:  2016-10-06       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.